Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis
about
sameAs
Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategiesCyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular riskLow-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time.Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities.Valdecoxib for the management of chronic and acute pain.Do selective COX-2 inhibitors increase the risk of cerebrovascular events? A meta-analysis of randomized controlled trials.Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.Prostacyclin: an inflammatory paradox.Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.Selective COX-2 inhibitors and risk of myocardial infarction.Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.Nonsteroidal anti-inflammatory drugs and the heart: what is the danger?Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.Postcraniotomy headache.
P2860
Q28200569-3A8F1775-0B11-433C-8829-A8AF86AF8316Q28219220-210F7608-182F-4861-84C8-0A0135EFB3DAQ33292053-6B2FD9B7-0F4A-4A5D-BD0B-091058E309DFQ34245387-15CEE484-8847-4EE1-98A2-C49F0B15A6D4Q34557067-2C16D141-7D02-4825-A050-C09D6BBDD9A3Q34592340-7834B7BB-E4F4-4A4E-8407-069821E8FA24Q34651032-98C95602-402C-48E7-9CD2-391FEC4B643AQ35025863-FDD90EB3-5B26-455A-9277-76A83242B1FFQ35769055-FC003AD4-87CC-49BA-9ABF-FCD6B7B71BF8Q36173750-05B595A2-29F3-45E1-8B4C-9BEB86E57EBAQ36486905-0F057F54-E649-44D2-86E2-E0C778AAEE99Q37133897-BC0A1257-56B4-4712-A4A1-CFA7E222EB7CQ37862577-01B45062-F014-465F-88D2-654866BF2428Q38121010-CD9F06EB-B256-4DE2-A88A-74062A53793B
P2860
Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@ast
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@en
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@nl
type
label
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@ast
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@en
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@nl
prefLabel
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@ast
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@en
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@nl
P2093
P1476
Effects of the cyclooxygenase- ...... nts in patients with arthritis
@en
P2093
Andrew Whelton
Richard Roberts
Vibeke Strand
William B White
P304
P356
10.1097/01.MJT.0000127360.23508.04
P407
P577
2004-01-01T00:00:00Z